Limited Utility of Routine Surveillance MRI Following Chemoradiation for Advanced-Stage Oropharynx Carcinoma

Table 3

Primary site, staging, time to recurrence, and treatment outcome of locoregional failures.

Patient no.	Primary site	Stage	Site of failure	Time to failure detection, mon.	Salvage therapy	Clinical status
Locoregional recurrent disease
1	BOT	T2N2b	Local	5	Surgery	DOD
2	BOT	T3N2b	Local	40	Brachytherapy	Alive^∗
3	BOT	T1N2b	Regional	11	Chemotherapy	DOD
4	BOT	T2N2b	Regional	26	Surgery	Alive^†

DOD, died of disease
∗ No evidence of disease at 26 months after high-dose-rate brachytherapy and chemotherapy
† No evidence of disease at 25 months after neck dissection